ARTICLE | Company News
MabVax Therapeutics, Rockefeller University deal
September 7, 2015 7:00 AM UTC
MabVax and the university’s laboratory of molecular genetics and immunology partnered to optimize MabVax’s HuMab 5B1 Fc receptor-mediated antibody function and explore the mechanism of Fc variants of...